Lynn Kirkpatrick
Chief Scientific Officer, Cascadian Therapeutics, Inc.
Companies
- Ensysce BiosciencesBoard member Jul 2, 2021 to May 27, 20221
- Ensysce BiosciencesChief executive officer Jul 2, 2021 to May 27, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Ensysce Biosciences ENSC381,851 shares2$197.9K at $0.52May 26, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- May 26, 2022Bought 27,000 shares at $0.53 of Ensysce Biosciences2
- May 25, 2022Bought 70,000 shares at $0.49 of Ensysce Biosciences2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAREnsysce Biosciences, Board member
- 2